Osteopenia in Alcoholics: Effect of Alcohol Abstinence

Osteopenia in Alcoholics: Effect of Alcohol Abstinence
复制标题

DOI:
10.1093/alcalc/agp038
复制
发表时间:
2009-09-01
影响因子:
2.8
通讯作者:
de los Angeles Gomez-Rodriguez, Maria
de los Angeles Gomez-Rodriguez, Maria
中科院分区:
医学3区
文献类型:
--
作者:
Alvisa-Negrin, Julio;Gonzalez-Reimers, Emilio;de los Angeles Gomez-Rodriguez, Maria

文献摘要

被引文献

相似文献

目的:本研究的目的是评估酗酒者的骨矿物质密度(BMD)和含量(BMC)、骨钙素、血清端肽、甲状旁腺激素和维生素D,并确定戒酒6个月是否会导致这些参数的变化。方法:测定28例正常对照和77例酒精中毒患者血清骨钙素、胰岛素样生长因子1 (IGF-1)、末端肽(40例)和125例二羟基维生素D,其中48例在6个月后再次测定。在研究开始时和6个月后,所有患者都使用Hologic QDR-2000骨密度仪(Waltham, MA, USA)对骨密度进行了全身评估。结果:患者血清端肽水平(0.59 +/- 0.40 vs 0.19 +/- 0.10 nmol/100 ml, P < 0.001)、IGF-1水平(中位数= 49,四分位间距(IQR) = 31-121 ng/ml vs 135, IQR = 116-237 ng/ml, P < 0.001)、维生素D水平(26.5,IQR = 17.0-37.8 pg/ml vs 82.4, IQR = 60.9-107.4 pg/ml, P < 0.001)、骨钙素水平(2.1,IQR = 1.1-3.6 ng/ml vs 6.65, IQR = 4.9-8.8 ng/ml, P < 0.001)均高于对照组。患者还表现出较低的骨密度值、骨骼多个水平的Z-和t -评分以及总BMC减少。6个月后,继续饮酒的人骨量减少,而不饮酒的人骨量没有变化或增加,尤其是骨盆、右臂、总骨密度和BMC的差异明显。与此同时,不喝酒的人骨钙素显著增加(而继续喝酒的人则有所减少)。两组血清端肽均升高。结论:酒精摄入导致骨质减少和血清骨钙素下降,戒酒后情况有所改善,而继续饮酒者两项指标均恶化。
Aims: The aims of this study were to assess bone mineral density (BMD) and content (BMC), osteocalcin, serum telopeptide, PTH and vitamin D in alcoholics, and to determine if a 6-month period of abstinence leads to changes in these parameters. Methods: Serum osteocalcin, insulin-like growth factor 1 (IGF-1), telopeptide (40 patients) and 1,25 dihydroxyvitamin D, were measured in 28 controls and 77 alcoholic patients, 48 of whom were evaluated again 6 months later. All patients underwent whole-body assessment of BMD by a Hologic QDR-2000 (Waltham, MA, USA) bone densitometer, at the beginning of the study and 6 months later. Results: Patients showed higher serum telopeptide levels (0.59 +/- 0.40 versus 0.19 +/- 0.10 nmol/100 ml, P < 0.001), lower IGF-1 [median = 49, interquartile range (IQR) = 31-121 ng/ml versus 135, IQR = 116-237 ng/ml, P < 0.001], vitamin D [26.5, IQR = 17.0-37.8 pg/ml versus 82.4 (IQR = 60.9-107.4 pg/ml, P < 0.001] and osteocalcin (2.1, IQR = 1.1-3.6 ng/ml versus 6.65, IQR = 4.9-8.8 ng/ml, P < 0.001) than those in controls. Patients also showed lower BMD values, Z- and T-scores at many levels of the skeleton and reduced total BMC. After 6 months, those who continued drinking showed a loss of bone mass, whereas those who abstained showed either no change or increase, differences being especially marked at pelvis, right arm and total BMD and BMC. Simultaneously, abstainers showed a significant increase in osteocalcin (versus a decrease among those who continued drinking). Serum telopeptide increased in both groups. Conclusion: Ethanol consumption leads to osteopenia, and decreased serum osteocalcin, which improve with abstinence, whereas those who continue drinking show a worsening of both parameters.